Predictors of As-Needed Ranibizumab Injection Frequency in Patients with Macular Edema Following Retinal Vein Occlusion.

American journal of ophthalmology(2023)

Cited 0|Views3
No score
Abstract
Greater baseline DRIL and higher CST at 3 months after starting ranibizumab treatment are associated with more frequent ranibizumab injections in PRN-treated patients with macular edema due to RVO.
More
Translated text
Key words
macular edema,injection,as-needed
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined